Хайдер Варрайч - Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний
- Название:Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний
- Автор:
- Жанр:
- Издательство:Литагент Альпина
- Год:2021
- Город:Москва
- ISBN:9785961473445
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Хайдер Варрайч - Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний краткое содержание
Вы узнаете о строении и функциях сердца и коронарных сосудов, о самых распространенных болезнях, их диагностике, лекарствах, а также о плюсах и минусах популярных методов лечения – катетеризации, кардиостимуляции и электроимпульсной терапии. Книга полна историй из практики автора и его коллег и отсылок к истории медицинской науки.
Хайдер Варрайч объясняет, почему женщины страдают теми же сердечными заболеваниями, что и мужчины, но тип заболевания у них совершенно иной, что общего у коронарных и онкологических заболеваний, как эволюция могла привести нас к настоящей эпидемии ишемической болезни, рассуждает о нынешнем состоянии мировой клинической кардиологии и перспективах ее развития в эпоху внедрения искусственного интеллекта.
Сердце, которое мы не знаем. История важнейших открытий и будущее лечения сердечно-сосудистых заболеваний - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
262
Ahmed A., Sorajja P., Pai A., et al. Prospective Evaluation of the Eyeball Test for Assessing Frailty in Patients with Valvular Heart Disease. Journal of the American College of Cardiology. 2016;68:2911–2.
263
Christenson J., Innes G., McKnight D., et al. A Clinical Prediction Rule for Early Discharge of Patients with Chest Pain. Annals of Emergency Medicine. 2006;47:1–10.
264
Fanaroff A. C., Rymer J. A., Goldstein S. A., Simel D. L., Newby L. K. Does This Patient with Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review. Journal of the American Medical Association. 2015;314:1955–65.
265
Obrastzow W. P., Straschesko N. D. Zur Kenntnis der Thrombose der Koronararterien des Herzens (To Note the Thrombosis of the Coronary Arteries of the Heart). Zeitschrift für klinische Medizin. 1910;71:116–32.
266
Yeh R. W., Sidney S., Chandra M., Sorel M., Selby J. V., Go AS. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. New England Journal of Medicine. 2010;362:2155–65.
267
Там же.
268
Parsons T. The Sick Role and the Role of the Physician Reconsidered. Milbank Memorial Fund Quarterly: Health and Society. 1975;53:257–78.
269
Galdas P., Cheater F., Marshall P. What Is the Role of Masculinity in White and South Asian Men’s Decisions to Seek Medical Help for Cardiac Chest Pain? Journal of Health Services Research & Policy. 2007;12:223–9.
270
French D. P., Cooper A., Weinman J. Illness Perceptions Predict Attendance at Cardiac Rehabilitation Following Acute Myocardial Infarction: A Systematic Review with Meta-Analysis. Journal of Psychosomatic Research. 2006;61:757–67.
271
Chen S.L, Tsai. J.C., Chou KR. Illness Perceptions and Adherence to Therapeutic Regimens Among Patients with Hypertension: A Structural Modeling Approach. International Journal of Nursing Studies. 2011;48:235–45.
272
Beck R. S., Daughtridge R, Sloane P. D. Physician-Patient Communication in the Primary Care Office: A Systematic Review. Journal of the American Board of Family Practice. 2002;15:25–38.
273
Egbert L. D., Battit G. E., Welch C. E., Bartlett M. K. Reduction of Postoperative Pain by Encouragement and Instruction of Patients. A Study of Doctor-Patient Rapport. New England Journal of Medicine. 1964;270:825–7.
274
Alpert J. S., Thygesen K., Antman E., Bassand J. P. Myocardial Infarction Redefined – A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Journal of the American College of Cardiology. 2000;36:959–69.
275
Rahman A., Broadley S. A. Review Article: Elevated Troponin: Diagnostic Gold or Fool’s Gold? Emergency Medicine Australasia. 2014;26:125–30.
276
Autier P., Boniol M., Koechlin A., Pizot C., Boniol M. Effectiveness of and Overdiagnosis from Mammography Screening in the Netherlands: Population-Based Study. British Medical Journal. 2017;359: j5224.
277
Ilic D., Neuberger M. M., Djulbegovic M., Dahm P. Screening for Prostate Cancer. Cochrane Database of Systematic Reviews. 2013: CD004720.
278
Yudkin J. S., Montori V. M. The Epidemic of Pre-Diabetes: The Medicine and the Politics. British Medical Journal. 2014;349: g4485.
279
Moynihan R. Caution! Diagnosis Creep. Australian Prescriber. 2016;39:30–1.
280
Than M., Herbert M., Flaws D., et al. What Is an Acceptable Risk of Major Adverse Cardiac Event in Chest Pain Patients Soon After Discharge from the Emergency Department?: A Clinical Survey. International Journal of Cardiology. 2013;166:752–4.
281
Moynihan R. N., Cooke G. P., Doust J. A., Bero L., Hill S., Glasziou P. P. Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-Sectional Study of Common Conditions in the United States. PLOS Medicine. 2013;10: e1001500.
282
Там же.
283
Upchurch C. T., Barrett E. J. Clinical Review: Screening for Coronary Artery Disease in Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism. 2012;97:1434–42.
284
Reed S, Pearson S. ICER. Choosing Wisely Recommendation Analysis: Prioritizing Opportunities for Reducing Inappropriate Care. Preoperative Stress Testing. 2016.
285
George Lakoff and Mark Johnson. Metaphors We Live By. 1st ed. Chicago, IL: University of Chicago Press; 2003.
286
Goff S. L., Mazor K. M., Ting H. H., Kleppel R., Rothberg M. B. How Cardiologists Present the Benefits of Percutaneous Coronary Interventions to Patients with Stable Angina: A Qualitative Analysis. JAMA Internal Medicine. 2014;174:1614–21.
287
The Widow Maker Heart Attack. January 2015. https://myheart.net/articles/thewidowmaker/.
288
Al-Lamee R., Thompson D., Dehbi H. M., et al. Percutaneous Coronary Intervention in Stable Angina (ORBITA): A Double-Blind, Randomised Controlled Trial. Lancet. 2018;391:31–40.
289
Badawy M. K., Deb P., Chan R., Farouque O. A Review of Radiation Protection Solutions for the Staff in the Cardiac Catheterisation Laboratory. Heart, Lung and Circulation. 2016;25:961–7.
290
CABG напоминает написанием слово cabbage – капуста.
291
Menzoian J. O., Koshar A. L., Rodrigues N. Alexis Carrel, Rene Leriche, Jean Kunlin, and the History of Bypass Surgery. Journal of Vascular Surgery. 2011;54:571–4.
292
Head S. J., Kieser T. M., Falk V., Huysmans HA, Kappetein AP. Coronary Artery Bypass Grafting: Part 1–The Evolution over the First 50 Years. European Heart Journal. 2013;34:2862–72.
293
JD R. New Surgery for Ailing Hearts. Reader’s Digest. 71:70 1957.
294
Cobb L. A., Thomas G. I., Dillard D. H., Merendino K. A., Bruce R. A. An Evaluation of Internal-Mammary-Artery Ligation by a Double-Blind Technic. New England Journal of Medicine. 1959;260:1115–8.
295
Shroyer A. L., Grover F. L., Hattler B., et al. On-Pump versus Off-Pump Coronary-Artery Bypass Surgery. New England Journal of Medicine. 2009;361:1827–37.
296
ElBardissi A.W., Aranki S. F., Sheng S., O’Brien S.M., Greenberg C. C., Gammie J. S. Trends in Isolated Coronary Artery Bypass Grafting: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Journal of Thoracic and Cardiovascular Surgery. 2012;143:273–81.
297
Forssmann W. Experiments on Myself. Memoirs of a Surgeon in Germany. New York: St. Martin’s; 1974.
298
Forssmann W. Die Sondierung des rechten Herzens. Klinische Wochenschrift. 1929;8:2085–7.
299
Heiss H. W. Werner Forssmann: A German Problem with the Nobel Prize. Clinical Cardiology. 1992;15:547–9.
300
Ryan T. J. The Coronary Angiogram and Its Seminal Contributions to Cardiovascular Medicine Over Five Decades. Circulation. 2002;106:752–6.
301
Sheldon W. C. F. Mason Sones, Jr. – Stormy Petrel of Cardiology. Clinical Cardiology. 1994;17:405–7.
302
Shrager J. B. The Vineberg Procedure: The Immediate Forerunner of Coronary Artery Bypass Grafting. Annals of Thoracic Surgery. 1994;57:1354–64.
303
Sheldon. F. Mason Sones.
304
Hurst J. W., King S. B., 3rd, Greene L. In Memory of Andreas Roland Gruentzig and Margaret Anne Thornton Gruentzig. American Journal of Cardiology. 1986;57:333–6.
305
Там же.
306
Barton M., Gruntzig J., Husmann M., Rosch J. Balloon Angioplasty – The Legacy of Andreas Gruntzig, M.D. (1939–1985). Frontiers in Cardiovascular Medicine. 2014; 1:15.
307
Hurst J. W. The First Coronary Angioplasty as Described by Andreas Gruentzig. American Journal of Cardiology. 1986;57:185–6.
308
Byrne R..A., Capodanno D., Mylotte D., Serruys P. W. State of the Art: 40 Years of Percutaneous Cardiac Intervention. EuroIntervention. 2017;13:621–4.
309
Gruntzig A. Transluminal Dilatation of Coronary-Artery Stenosis. Lancet. 1978;1:263.
310
Meier B. The First Patient to Undergo Coronary Angioplasty-23-Year Follow-Up. New England Journal of Medicine. 2001;344:144–5.
311
International Trade Administration. Department of Commerce. 2016 Top Markets Report: Medical Devices. Overview and Key Findings. www.trade.gov/topmarkets/pdf/Medical_Devices_Executive_Summary.pdf.
312
Psaty B. M., Boineau R., Kuller L. H., Luepker R. V. The Potential Costs of Upcoding for Heart Failure in the United States. American Journal of Cardiology. 1999;84:108–9, A9.
313
Coding in the Anti-Fraud Era. Skirt the Upcoding Spotlight. Hospital Peer Review. 1997;22:141–3.
314
Desai N. R., Bradley S. M., Parzynski C. S., et al. Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention. Journal of the American Medical Association. 2015;314:2045–53.
315
Gupta A., Yeh R. W., Tamis-Holland J.E., et al. Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients. JACC Cardiovascular Interventions. 2016;9:2077–85.
316
Boden W. E., O’Rourke R.A., Teo K. K., et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine. 2007;356:1503–16.
317
Sedlis S. P., Hartigan P. M., Teo K. K., et al. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. New England Journal of Medicine. 2015;373:1937–46.
318
Al-Lamee, Thompson, Dehbi, et al. Percutaneous Coronary Intervention.
319
Carrozza J. P., Levin T. Periprocedural Complications of Percutaneous Coronary Intervention. UpToDate. Last updated February 8, 2018.
320
Fornell D. Tempering the Bioresorbable Stent Euphoria Following FDA Clearance of the Absorb. August 2016. www.dicardiology.com/content/blogs/tempering-bioresorbable-stent-euphoria-following-fda-clearance-absorb.
321
De Rosa R., Silverio A., Varricchio A., et al. Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes. American Journal of Cardiology. 2018;122:61–8.
Читать дальшеИнтервал:
Закладка:
